Literature DB >> 27663561

Pharmacists' guide to the management of organ donors after brain death.

Catherine Korte1, Jennifer L Garber2, Jillian L Descourouez3, Katelyn R Richards4, Karen Hardinger5.   

Abstract

PURPOSE: This article reviews organ donor pathophysiology as it relates to medication use with the goal of maximizing the successful procurement and transplantation of donor organs.
SUMMARY: The number of patients requiring organ transplantation continues to grow, yet organ donation rates remain flat, making it critical to appropriately manage each organ donor in order to ensure viability of all transplantable organs. The care given to one organ donor is tantamount to the care of several transplant recipients. Aggressive donor management ensures that the largest number of organs can be successfully procured and improves the organs' overall quality. Hospital pharmacists are responsible for processing orders and preparing the medications outlined in donor management algorithms developed by their respective medical systems. It is important that pharmacists understand the details of the medications used in these protocols in order to critically evaluate each medication order and appropriately manage the donor. Typical medications used in organ donors after brain death include medications for blood pressure management and fluid resuscitation, medications necessary for electrolyte management, blood products, vasopressors, hormone replacement therapy, antiinfectives, anticoagulants, paralytics, and organ preservation solutions.
CONCLUSION: It is essential to provide optimal pharmacotherapy for each organ donor to ensure organ recovery and donation. Typical medications used in organ donors include agents for blood pressure management and fluid resuscitation, medications necessary for electrolyte management, blood products, vasopressors, hormone replacement therapy, antiinfectives, anticoagulants, paralytics, and organ preservation solutions.
Copyright © 2016 by the American Society of Health-System Pharmacists, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27663561     DOI: 10.2146/ajhp150956

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  2 in total

Review 1.  Specialized Donor Care Facility Model and Advances in Management of Thoracic Organ Donors.

Authors:  Amit Bery; Gary Marklin; Akinobu Itoh; Daniel Kreisel; Tsuyoshi Takahashi; Bryan F Meyers; Ruben Nava; Benjamin D Kozower; Hailey Shepherd; G Alexander Patterson; Varun Puri
Journal:  Ann Thorac Surg       Date:  2021-01-07       Impact factor: 5.102

2.  Use of Argatroban in Donor Lung Procurement: A Case Report.

Authors:  Limi Sharif; M Andrew Millis; Caitlin T Demarest; Ashraf Abou El Ela; Katie A McMurry; Dennis Lyu; Elliot Wakeam
Journal:  Am J Case Rep       Date:  2021-11-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.